Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTaking Wegovy a day late does not mean you've missed the dose entirely. If your usual injection day passes and you remember within five days, you can still take it and then return to your normal weekly schedule from that point. If more than five days have elapsed, skip that dose and wait for your next scheduled day. This is the guidance set out in the NHS patient information for semaglutide. Wegovy (semaglutide) is a once-weekly subcutaneous injection, so its active level in your body falls gradually after a missed day rather than dropping off a cliff — which is why the five-day window exists. As with all prescription-only medicines, your prescriber and the Patient Information Leaflet that comes with your pen are the definitive reference for your personal situation.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A concern that comes up regularly (and understandably so) is that taking Wegovy even one day late will undo weeks of effort. It won't. Semaglutide has a half-life of roughly seven days, which is precisely why once-weekly dosing works at all. Twenty-four hours after a missed injection, the medicine is still meaningfully active in your system. The appetite-regulating effect fades gradually, not instantly.
You may notice a little more hunger toward the end of the week even on a perfect schedule, so a single late dose is unlikely to feel dramatically different. What you should not do is try to compensate by injecting twice in close succession or cutting the gap to just a day or two before your next scheduled dose. That approach can intensify gastrointestinal side effects without adding meaningful benefit. The five-day rule in the Patient Information Leaflet exists because it reflects how the medicine actually behaves in the body, not as an arbitrary cutoff.
If you want a broader sense of how semaglutide works once it is in your system, that page covers the mechanism in more detail.
Say your usual injection day is Monday. You get to Wednesday morning and realise you forgot. Under the guidance from the NHS semaglutide page, you inject on Wednesday, then resume Monday the following week as normal. The gap between Wednesday's injection and the following Monday is only five days, which is fine, slightly closer together than usual, but within the range the prescribing information accounts for.
Now suppose it is Saturday evening and you have only just noticed. That is five days after Monday, sitting right at the edge of the window. Check the exact date and time against your usual injection day and follow the Patient Information Leaflet precisely. If you are ever genuinely unsure, our support team is available seven days a week and can help you think it through.
Beyond five days, the guidance is clear: do not inject for that missed week. Wait for Monday as normal. Injecting a late dose at that point would mean two doses arriving in close succession, which is the scenario most likely to cause nausea and other gut symptoms.
For related timing questions, people who have wondered what happens if you take semaglutide a day early will find the considerations follow similar logic and are worth reading alongside this.
For most people, a single late injection does not meaningfully change the side-effect picture. Where things can get bumpier is if you have recently moved to a higher dose. When the body is still adjusting to 0.5mg, 1.0mg or 1.7mg, the gastrointestinal effects tend to be most noticeable in the days after each injection. A delay at that stage does not make those effects worse on its own, but arriving at the next dose sooner than seven days (by injecting late and then resuming on your original day) can produce a slightly shorter gap than your system is used to.
The titration schedule (starting at 0.25mg and stepping up approximately every four weeks as directed by your prescriber) is not derailed by the occasional late injection. Persistent disruptions to the schedule are a different matter and worth a conversation with your prescriber before your next dose review. If you are curious about what to expect across the full Wegovy journey, the Wegovy overview covers the progression in plain terms.
One practical note from a question our prescribers hear often: if you regularly find it difficult to remember a weekly injection, a short-term phone reminder or pairing the injection with a consistent weekly event (a Sunday evening routine, for example) tends to help more than relying on memory alone.
You may also find it useful to read about what happens if you take Wegovy two days early, which covers the shorter-gap scenario and what to expect when the timing shifts in the other direction.
A single late dose, handled according to the five-day rule, does not require a clinical review on its own. However, there are situations where reaching out to your prescriber is the right call: if you have missed multiple doses in a row and are unsure how that affects your treatment, if you are unsure whether a late injection caused an unusual side effect, or if you are thinking about pausing treatment for a planned reason (travel, surgery, pregnancy planning).
The MHRA's Yellow Card scheme allows you to report any unexpected side effects from semaglutide, and doing so contributes to the ongoing monitoring of medicines like Wegovy in the UK. The Yellow Card reporting page is open to patients as well as healthcare professionals.
If you are not yet on Wegovy but are considering whether it might be suitable for you, starting a free consultation is the first step. A named prescriber (a real clinician, not software) reviews every application the same day it comes in. People who are still finding their feet with the weekly schedule sometimes ask what happens if they take their Wegovy a day early, and that page is a helpful companion read if timing flexibility is something you are thinking about.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.